A detailed history of Td Private Client Wealth LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Td Private Client Wealth LLC holds 21,123 shares of EW stock, worth $1.4 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
21,123
Holding current value
$1.4 Million
% of portfolio
0.06%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$84.3 - $94.31 $1.78 Million - $1.99 Million
21,123 New
21,123 $1.95 Billion
Q1 2024

Aug 16, 2024

SELL
$72.54 - $95.56 $109,825 - $144,677
-1,514 Reduced 6.25%
22,706 $2.17 Billion
Q4 2023

Aug 16, 2024

BUY
$61.71 - $77.76 $497,629 - $627,056
8,064 Added 49.91%
24,220 $1.85 Billion
Q3 2023

Aug 16, 2024

BUY
$69.28 - $93.38 $18,982 - $25,586
274 Added 1.73%
16,156 $1.12 Billion
Q2 2023

Aug 16, 2024

BUY
$81.41 - $94.33 $101,111 - $117,157
1,242 Added 8.48%
15,882 $1.5 Billion
Q1 2023

Aug 16, 2024

BUY
$74.26 - $84.51 $16,337 - $18,592
220 Added 1.53%
14,640 $1.21 Billion
Q4 2022

Aug 16, 2024

SELL
$68.3 - $87.44 $956,268 - $1.22 Million
-14,001 Reduced 49.26%
14,420 $1.08 Billion
Q3 2022

Aug 16, 2024

SELL
$82.37 - $107.29 $50,163 - $65,339
-609 Reduced 2.1%
28,421 $2.35 Billion
Q2 2022

Aug 16, 2024

SELL
$86.5 - $128.27 $12,542 - $18,599
-145 Reduced 0.5%
29,030 $2.77 Billion
Q1 2022

Aug 16, 2024

BUY
$101.96 - $128.34 $321,989 - $405,297
3,158 Added 12.14%
29,175 $3.43 Billion
Q4 2021

Aug 16, 2024

SELL
$106.37 - $130.68 $428,564 - $526,509
-4,029 Reduced 13.41%
26,017 $3.37 Billion
Q3 2021

Aug 16, 2024

BUY
$102.91 - $122.75 $918,265 - $1.1 Million
8,923 Added 42.24%
30,046 $3.4 Billion
Q2 2021

Aug 16, 2024

BUY
$83.84 - $104.76 $26,158 - $32,685
312 Added 2.44%
13,090 $1.36 Billion
Q1 2021

Aug 16, 2024

BUY
$78.68 - $90.67 $86,311 - $99,464
1,097 Added 9.39%
12,778 $1.07 Billion
Q4 2020

Aug 16, 2024

BUY
$71.69 - $91.23 $104,667 - $133,195
1,460 Added 14.28%
11,681 $1.07 Billion
Q3 2020

Aug 16, 2024

SELL
$67.19 - $87.44 $60,941 - $79,308
-907 Reduced 8.15%
10,221 $816 Million
Q2 2020

Aug 16, 2024

BUY
$57.54 - $76.95 $492,197 - $658,230
8,554 Added 332.32%
11,128 $769 Million
Q1 2020

Aug 16, 2024

SELL
$52.41 - $81.0 $20,859 - $32,238
-398 Reduced 13.39%
2,574 $486 Million
Q4 2019

Aug 16, 2024

SELL
$71.7 - $82.09 $1.3 Million - $1.49 Million
-18,151 Reduced 85.93%
2,972 $693 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Td Private Client Wealth LLC Portfolio

Follow Td Private Client Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Private Client Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Td Private Client Wealth LLC with notifications on news.